Solventum (SOLV) Research & Development (2023 - 2026)
Solventum's (SOLV) quarterly Research & Development came in at $189.0 million in Q1 2026, down 2.07% YoY from $193.0 million in Q1 2025, and up 8.0% on a QoQ basis from $175.0 million in Q4 2025.
Solventum (SOLV) Research & Development (2023 - 2026) Analysis & Trends
Solventum (SOLV) has 4 years of Research & Development data on file, last reported at $189.0 million in Q1 2026.
- Quarterly Research & Development fell 2.07% year-over-year to $189.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $736.0 million (down 4.79% YoY) and the FY2025 annual result came in at $739.0 million, down 4.65% from the prior year.
- Research & Development rose to $189.0 million in Q1 2026, from $175.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $199.0 million in Q4 2024 to a low of $175.0 million in Q4 2025.
- A 4-year average of $189.4 million and a median of $190.0 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development climbed 5.0% — and 2025, when it declined 12.06%.
- Tracing SOLV's Research & Development over 4 years: stood at $190.0 million in 2023, then increased by 4.74% to $199.0 million in 2024, then decreased by 12.06% to $175.0 million in 2025, then advanced by 8.0% to $189.0 million in 2026.
- The last three Research & Development figures came in at $189.0 million (Q1 2026), $175.0 million (Q4 2025), and $183.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 102.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 178.00 Mn |
| Mar 31, 2026 | 189.00 Mn |
| Dec 31, 2025 | 175.00 Mn |
| Sep 30, 2025 | 183.00 Mn |
| Jun 30, 2025 | 189.00 Mn |
| Mar 31, 2025 | 193.00 Mn |
| Dec 31, 2024 | 199.00 Mn |
| Sep 30, 2024 | 189.00 Mn |
| Jun 30, 2024 | 192.00 Mn |
| Mar 31, 2024 | 195.00 Mn |
| Dec 31, 2023 | 190.00 Mn |
| Sep 30, 2023 | 180.00 Mn |
| Jun 30, 2023 | 193.00 Mn |
| Mar 31, 2023 | 195.00 Mn |